Cancer stem cells – University of Michigan Comprehensive …

Cancer stem cells are the small number of cells within a tumor that drive the tumor's growth. These cells generally make up just 1% to 3% of all cells in a tumor Watch the video with Max Wicha, M.D., director emeritus of the University of Michigan Comprehensive Cancer Cancer and learn more about stem cell research

If you are having trouble viewing the video, watch it on our YouTube channel.

At the U-M Comprehensive Cancer Center, we believe treatments designed to target and destroy cancer stem cells will revolutionize how we treat cancer. Over the last 30 years, researchers have developed more effective treatments for cancers like childhood leukemia, Hodgkin's disease and testicular cancer.

Death rates for some common cancers, like breast and prostate cancer, have gone down due to advances in early detection and prevention. However, the survival rate for patients with many advanced cancers has not changed significantly for decades, and cancer is still the second-most common cause of death in the United States.

Instead of trying to kill all the cells in a tumor with chemotherapy or radiation, we believe it would be more effective to use treatments targeted directly at these so-called cancer stem cells. If the stem cells were eliminated, the cancer would be unable to grow and spread to other locations in the body.

The U-M Comprehensive Cancer Center is one of only a few research institutions in the United States and Canada that has made an institutional commitment to cancer stem cell research.

Organized teams of U-M scientists are studying cancer stem cells in many different types of cancer:

By working together and sharing information, Cancer Center scientists hope to make progress more rapidly than would be possible for individual scientists working alone.

We believe new treatments designed to target and destroy cancer stem cells could revolutionize the way physicians treat cancer. Our goal is to be the world's leader in research on cancer stem cells and in the development of new stem cell-based therapies for cancer patients.

Every organ and type of tissue in the body contains a small number of what scientists call "adult" or "tissue" stem cells. Since most cells in the body live for just a short time, the body needs to keep making new cells to replace them.

Adult stem cells ensure a continuous supply of new cells to replace old cells that wear out or are destroyed.

In 2003, U-M scientists were the first in the world to identify cancer stem cells in a solid tumor, finding them in breast tumors. Since then, other Cancer Center scientists have discovered and isolated cancer stem cells in pancreatic cancer (2007), in head and neck cancer (2007) and in an aggressive brain cancer called glioblastoma (2009).

Even under a microscope, there's no way to distinguish cancer stem cells from other malignant cells just by looking at them. To identify stem cells, scientists use specialized equipment to detect specific proteins on the cell's surface.

These proteins are not found on regular cancer cells. A biochemical assay developed at the U-M Cancer Center can identify breast cancer stem cells.

The ultimate test to prove that cells are true cancer stem cells is to inject cells from a human tumor into mice that are genetically engineered to lack a cancer-fighting immune system. If the mouse does not get cancer, scientists know the injected cells were not stem cells, because ordinary tumor cells will divide a few times and then die. But if the mouse develops a tumor with the same types of cells as the human tumor, scientists know that the injected cells were true cancer stem cells.

By analyzing the genes that are active in a patient's cancer stem cells and counting the number of stem cells in a tumor, physicians could identify patients at high risk for advanced, aggressive disease.

New therapies designed to target stem cells could eliminate cancer without the risks and side effects of current treatments that also destroy healthy cells in the body. Destroying cancer stem cells in the original tumor could reduce the risk of deadly metastasis, where malignant cells move from the primary tumor to other places in the body. Finally, by killing the cells driving the tumor's growth, treatments targeted at cancer stem cells could eliminate recurrences of the disease.

Scientists don't know for sure. Since chemotherapy and radiation kill cells that divide often, stem cells may be less vulnerable because they rarely divide. Some scientists believe cancer stem cells may have genetic mutations that make them resistant to damage from chemotherapy or radiation, or cancer stem cells may be able to repair DNA damage more rapidly than normal cells.

Back to top

Updated 06.2016

View original post here:

Cancer stem cells - University of Michigan Comprehensive ...